IDUA Polyclonal Antibody

This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans| dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I).

The IDUA Polyclonal Antibody is a highly specific and sensitive immunological tool designed for the detection and quantification of the IDUA protein. This antibody has been meticulously developed and rigorously validated to ensure optimal performance in various applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assay (ELISA).

The IDUA Polyclonal Antibody exhibits exceptional affinity and selectivity towards the IDUA protein, making it an ideal choice for researchers and scientists working in the field of lysosomal storage disorders. This antibody recognizes both the native and denatured forms of the IDUA protein, enabling accurate and reliable detection across a wide range of sample types.

With its superior sensitivity, the IDUA Polyclonal Antibody allows for the detection of even low abundance IDUA protein levels, facilitating precise quantification and analysis. Its robust performance ensures consistent and reproducible results, making it an indispensable tool for both basic research and clinical applications.

The IDUA Polyclonal Antibody is manufactured using state-of-the-art techniques and undergoes stringent quality control measures to guarantee batch-to-batch consistency and reliability. It is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation.

In summary, the IDUA Polyclonal Antibody is a highly reliable and efficient tool for the detection and quantification of the IDUA protein. Its exceptional sensitivity, specificity, and versatility make it an invaluable asset for researchers and clinicians alike, enabling advancements in the understanding and treatment of lysosomal storage disorders.